Research & Faculty

Diabetes, Obesity & Metabolism Research

Metabolic dysregulation may cause a number of chronic diseases and conditions. Diabetes, obesity, fatty liver disease, and atherosclerosis are among the most common, costly, and preventable of all health problems, and mainly due to dysregulation of lipid, glucose or energy metabolism. Diabetes, obesity, and non-alcoholic fatty liver disease account for 9.4%, 34%, and 30% of the US population, respectively. Atherosclerosis is the major cause for coronary heart disease, the No. 1 killer in the US. The Diabetes, Obesity and Metabolism Research Focus Area at NEOMED aims to build a collaborative internationally-recognized Center of Excellence for fundamental and translational research in diabetes, obesity and metabolism. The members of this group have expertise in studying bile acid, glucose, lipid and lipoprotein metabolism.


Yanqiao Zhang, M.D., FAHA, Director

More on Zhang

John Chiang, Ph.D.

More on Chiang

Yoon-Kwang Lee, Ph.D.

More on Lee

James Hardwick, Ph.D.

More on Hardwick

Takhar Kasumov, Ph.D.

More on Kasumov

Liya Yin, M.D., Ph.D.

More on Yin

Priya Raman, Ph.D.

More on Raman

Jessica Ferrell, Ph.D.

More on Ferrell

News & Stories


Yanqiao Zhang, M.D.
Professor of Integrative Medical Sciences
Director, Diabetes, Obesity & Metabolism Research Focus Area
Phone: 330.325.6693

Diabetes, Obesity & Metabolism Research

Research Focus Area at NEOMED